Where is Thermo Fisher Scientific (TMO) Headed According to Analysts?

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best medical stocks to buy now. Bank of America Securities analyst Michael Ryskin reiterated a Buy rating on Thermo Fisher Scientific Inc. (NYSE:TMO) on September 22, setting a price target of $560.00.

The same day, Eve Burstein from Bernstein also reiterated a Buy rating on the stock and set a price target of $570.00.

Similarly, Barclays upgraded Thermo Fisher Scientific Inc. (NYSE:TMO) to Overweight from Equal Weight on September 11, raising the price target to $550 from $490.

Thermo Fisher Scientific Inc. (NYSE:TMO) provides analytical instruments, reagents, equipment, software, and other services for analysis, research, diagnostics, and discovery. It operates through the Analytical Instruments, Life Sciences Solutions, Laboratory Products and Services, and Specialty Diagnostics segments.

While we acknowledge the potential of TMO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.